{"transactions":[{"id":4634167,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53619,"kind":"person","name":"Cavanagh Bethany J","position":1,"cik":"0002033155","reported_name":"Cavanagh Bethany J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance and Treasurer"}}],"security":"Common Stock","published_at":"2026-10-03T00:05:13.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":187,"price":24.41,"value":4564.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. 2019 Equity Incentive Plan on September 30, 2024. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 9, 2024."}],"balance_after":50984,"source":{"system":"sec-edgar","filing":"0001193125-26-412236","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2033155/000119312526412236/ownership.xml","form_type":"4"}},{"id":4626900,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":36344,"kind":"person","name":"Ciaramella Giuseppe","position":1,"cik":"0001786322","reported_name":"Ciaramella Giuseppe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2026-09-25T20:05:05.000Z","date":"2026-09-24","kind":"gift","planned":false,"acquired":false,"shares":123407,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On September 24, 2026, the reporting person contributed 123,407 shares of BEAM common stock to the Giuseppe Ciaramella Irrevocable Trust - 2026, of which the reporting person's spouse is trustee. The beneficiaries of the trust are the reporting person's spouse and children. The reporting person disclaims beneficial ownership of the securities held by the trust."}],"balance_after":130504,"source":{"system":"sec-edgar","filing":"0001193125-26-402814","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1786322/000119312526402814/ownership.xml","form_type":"4"}},{"id":701474,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":28026,"kind":"person","name":"Simon Amy","position":1,"cik":"0001963879","reported_name":"Simon Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-29T20:05:04.000Z","date":"2026-07-27","kind":"sale","planned":true,"acquired":false,"shares":16667,"price":25.7417,"value":429036.9139,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $25.32 to $26.05, inclusive. The Reporting Person undertakes to provide to Beam Therapeutics Inc. (\"BEAM\"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":85696,"source":{"system":"sec-edgar","filing":"0001193125-26-323640","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526323640/ownership.xml","form_type":"4"}},{"id":718098,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":28026,"kind":"person","name":"Simon Amy","position":1,"cik":"0001963879","reported_name":"Simon Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-02T20:05:03.000Z","date":"2026-06-30","kind":"sale","planned":true,"acquired":false,"shares":373,"price":34.73,"value":12954.29,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") 2019 Equity Incentive Plan on June 30, 2022. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2023."}],"balance_after":102363,"source":{"system":"sec-edgar","filing":"0001193125-26-294478","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526294478/ownership.xml","form_type":"4"}},{"id":721305,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-01T20:05:11.000Z","date":"2026-06-30","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock options were exercised and the shares of common stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On July 13, 2018, the Reporting Person was granted an option to purchase 539,645 shares of common stock, which vested as to 25% of the underlying shares on January 8, 2019 and in 36 equal monthly installments thereafter."}],"balance_after":205804,"derivative":{"exercise_price":1.03,"expiration_date":"2028-07-13","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001193125-26-292526","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526292526/ownership.xml","form_type":"4"}},{"id":721304,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-01T20:05:11.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":false,"shares":6337,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock options were exercised and the shares of common stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On July 13, 2018, the Reporting Person was granted an option to purchase 539,645 shares of common stock, which vested as to 25% of the underlying shares on January 8, 2019 and in 36 equal monthly installments thereafter."}],"balance_after":230804,"derivative":{"exercise_price":1.03,"expiration_date":"2028-07-13","underlying":"Common Stock","underlying_shares":6337},"source":{"system":"sec-edgar","filing":"0001193125-26-292526","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526292526/ownership.xml","form_type":"4"}},{"id":721303,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-01T20:05:11.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":false,"shares":18663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock options were exercised and the shares of common stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On May 8, 2018, the Reporting Person was granted an option to purchase shares of common stock, which vested as to 99,396 shares upon the achievement of a certain development milestone related to base editing applications. On April 3, 2024, the board of directors of BEAM determined that this performance condition was achieved, resulting in the vesting of 99,336 shares."}],"balance_after":9,"derivative":{"exercise_price":0.67,"expiration_date":"2028-05-08","underlying":"Common Stock","underlying_shares":18663},"source":{"system":"sec-edgar","filing":"0001193125-26-292526","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526292526/ownership.xml","form_type":"4"}},{"id":721302,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-07-01T20:05:11.000Z","date":"2026-06-30","kind":"sale","planned":true,"acquired":false,"shares":1900,"price":34.8437,"value":66203.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock options were exercised and the shares of common stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $34.83 to $34.85, inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1047205,"source":{"system":"sec-edgar","filing":"0001193125-26-292526","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526292526/ownership.xml","form_type":"4"}},{"id":721301,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-07-01T20:05:11.000Z","date":"2026-06-30","kind":"sale","planned":true,"acquired":false,"shares":23100,"price":34.2633,"value":791482.23,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock options were exercised and the shares of common stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $33.80 to $34.71, inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1049105,"source":{"system":"sec-edgar","filing":"0001193125-26-292526","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526292526/ownership.xml","form_type":"4"}},{"id":721300,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-07-01T20:05:11.000Z","date":"2026-06-30","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":1.03,"value":25750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock options were exercised and the shares of common stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025."}],"balance_after":1072205,"source":{"system":"sec-edgar","filing":"0001193125-26-292526","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526292526/ownership.xml","form_type":"4"}},{"id":721299,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-07-01T20:05:11.000Z","date":"2026-06-29","kind":"sale","planned":true,"acquired":false,"shares":11579,"price":35.9119,"value":415823.8901,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock options were exercised and the shares of common stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $35.60 to $36.18, inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1047205,"source":{"system":"sec-edgar","filing":"0001193125-26-292526","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526292526/ownership.xml","form_type":"4"}},{"id":721298,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-07-01T20:05:11.000Z","date":"2026-06-29","kind":"sale","planned":true,"acquired":false,"shares":13421,"price":35.1336,"value":471528.0456,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock options were exercised and the shares of common stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $34.55 to $35.50, inclusive. The Reporting Person undertakes to provide to Beam Therapeutics Inc. (\"BEAM\"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1058784,"source":{"system":"sec-edgar","filing":"0001193125-26-292526","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526292526/ownership.xml","form_type":"4"}},{"id":721297,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-07-01T20:05:11.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":true,"shares":6337,"price":1.03,"value":6527.11,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock options were exercised and the shares of common stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025."}],"balance_after":1072205,"source":{"system":"sec-edgar","filing":"0001193125-26-292526","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526292526/ownership.xml","form_type":"4"}},{"id":721296,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-07-01T20:05:11.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":true,"shares":18663,"price":0.67,"value":12504.21,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock options were exercised and the shares of common stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025."}],"balance_after":1065868,"source":{"system":"sec-edgar","filing":"0001193125-26-292526","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526292526/ownership.xml","form_type":"4"}},{"id":724960,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":28868,"kind":"organization","name":"FMR LLC","position":1,"cik":"0000315066","reported_name":"FMR LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remark 1"}}],"security":"Common Stock","published_at":"2026-06-29T18:17:18.000Z","date":"2026-06-26","kind":"sale","planned":false,"acquired":false,"shares":251488,"price":35.26,"value":8867466.88,"ownership":{"direct":false,"nature":"F-Prime Capital Partners Healthcare Fund V LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $35.00 to $35.88. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information."}],"balance_after":854583,"source":{"system":"sec-edgar","filing":"0001193125-26-288078","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/315066/000119312526288078/ownership.xml","form_type":"4"}},{"id":724959,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":28868,"kind":"organization","name":"FMR LLC","position":1,"cik":"0000315066","reported_name":"FMR LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remark 1"}}],"security":"Common Stock","published_at":"2026-06-29T18:17:18.000Z","date":"2026-06-25","kind":"sale","planned":false,"acquired":false,"shares":33372,"price":35.12,"value":1172024.64,"ownership":{"direct":false,"nature":"F-Prime Capital Partners Healthcare Fund V LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $35.00 to $35.39. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information."}],"balance_after":1106071,"source":{"system":"sec-edgar","filing":"0001193125-26-288078","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/315066/000119312526288078/ownership.xml","form_type":"4"}},{"id":730537,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":36344,"kind":"person","name":"Ciaramella Giuseppe","position":1,"cik":"0001786322","reported_name":"Ciaramella Giuseppe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-22T20:05:05.000Z","date":"2026-06-17","kind":"exercise","planned":false,"acquired":false,"shares":29000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to these stock options vested 25% on the first anniversary of the vesting commencement dates, February 26, 2018, and the remaining shares vested in 36 substantially equal monthly installments thereafter."}],"balance_after":56946,"derivative":{"exercise_price":1.03,"expiration_date":"2028-07-13","underlying":"Common Stock","underlying_shares":29000},"source":{"system":"sec-edgar","filing":"0001193125-26-277509","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526277509/ownership.xml","form_type":"4"}},{"id":730536,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":36344,"kind":"person","name":"Ciaramella Giuseppe","position":1,"cik":"0001786322","reported_name":"Ciaramella Giuseppe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-22T20:05:05.000Z","date":"2026-06-17","kind":"exercise","planned":false,"acquired":false,"shares":6505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to these stock options vested 25% on the first anniversary of the vesting commencement dates, February 26, 2018, and the remaining shares vested in 36 substantially equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":0.67,"expiration_date":"2028-05-08","underlying":"Common Stock","underlying_shares":6505},"source":{"system":"sec-edgar","filing":"0001193125-26-277509","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526277509/ownership.xml","form_type":"4"}},{"id":730535,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":36344,"kind":"person","name":"Ciaramella Giuseppe","position":1,"cik":"0001786322","reported_name":"Ciaramella Giuseppe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2026-06-22T20:05:05.000Z","date":"2026-06-17","kind":"exercise","planned":false,"acquired":true,"shares":29000,"price":1.03,"value":29870.0,"ownership":{"direct":true},"balance_after":253911,"source":{"system":"sec-edgar","filing":"0001193125-26-277509","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526277509/ownership.xml","form_type":"4"}},{"id":730534,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":36344,"kind":"person","name":"Ciaramella Giuseppe","position":1,"cik":"0001786322","reported_name":"Ciaramella Giuseppe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2026-06-22T20:05:05.000Z","date":"2026-06-17","kind":"exercise","planned":false,"acquired":true,"shares":6505,"price":0.67,"value":4358.35,"ownership":{"direct":true},"balance_after":224911,"source":{"system":"sec-edgar","filing":"0001193125-26-277509","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526277509/ownership.xml","form_type":"4"}},{"id":748059,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":11980,"kind":"person","name":"Shaw Christi","position":1,"cik":"0001702473","reported_name":"Shaw Christi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T20:05:13.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":19676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the first anniversary of the date of grant and immediately prior to the date of the next year's annual meeting of stockholders, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date."}],"balance_after":19676,"derivative":{"exercise_price":29.55,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":19676},"source":{"system":"sec-edgar","filing":"0001193125-26-259529","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526259529/ownership.xml","form_type":"4"}},{"id":748058,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40950,"kind":"person","name":"Walsh Kathleen E","position":1,"cik":"0001667866","reported_name":"Walsh Kathleen E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T20:05:10.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":19676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the first anniversary of the date of grant and immediately prior to the date of the next year's annual meeting of stockholders, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date."}],"balance_after":19676,"derivative":{"exercise_price":29.55,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":19676},"source":{"system":"sec-edgar","filing":"0001193125-26-259526","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526259526/ownership.xml","form_type":"4"}},{"id":748296,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":32216,"kind":"person","name":"MARAGANORE JOHN","position":1,"cik":"0001180432","reported_name":"MARAGANORE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T20:05:09.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":19676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the first anniversary of the date of grant and immediately prior to the date of the next year's annual meeting of stockholders, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date."}],"balance_after":19676,"derivative":{"exercise_price":29.55,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":19676},"source":{"system":"sec-edgar","filing":"0001193125-26-259524","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180432/000119312526259524/ownership.xml","form_type":"4"}},{"id":748057,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40949,"kind":"person","name":"Fishman Mark","position":1,"cik":"0001786003","reported_name":"Fishman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T20:05:08.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":19676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the first anniversary of the date of grant and immediately prior to the date of the next year's annual meeting of stockholders, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date."}],"balance_after":19676,"derivative":{"exercise_price":29.55,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":19676},"source":{"system":"sec-edgar","filing":"0001193125-26-259536","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526259536/ownership.xml","form_type":"4"}},{"id":748056,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T20:05:06.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":19676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the first anniversary of the date of grant and immediately prior to the date of the next year's annual meeting of stockholders, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date."}],"balance_after":19676,"derivative":{"exercise_price":29.55,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":19676},"source":{"system":"sec-edgar","filing":"0001193125-26-259534","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526259534/ownership.xml","form_type":"4"}},{"id":748053,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T20:05:05.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":19676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the first anniversary of the date of grant and immediately prior to the date of the next year's annual meeting of stockholders, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date."}],"balance_after":19676,"derivative":{"exercise_price":29.55,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":19676},"source":{"system":"sec-edgar","filing":"0001193125-26-259519","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526259519/ownership.xml","form_type":"4"}},{"id":814480,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-04-06T21:48:48.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":30078,"price":24.58,"value":739317.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") 2019 Equity Incentive Plan on each of March 31, 2022, March 31, 2023, March 31, 2024 and March 31, 2025. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 616 shares acquired by the Reporting Person under the BEAM Amended and Restated 2019 Employee Stock Purchase Plan on March 31, 2026."}],"balance_after":1047205,"source":{"system":"sec-edgar","filing":"0001193125-26-144086","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526144086/ownership.xml","form_type":"4"}},{"id":814479,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":28026,"kind":"person","name":"Simon Amy","position":1,"cik":"0001963879","reported_name":"Simon Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-06T21:44:35.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":6700,"price":24.58,"value":164686.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") 2019 Equity Incentive Plan on each of March 31, 2022, March 31, 2023, March 31, 2024 and March 31, 2025. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 183 and 138 shares acquired by the Reporting Person under the BEAM Amended and Restated 2019 Employee Stock Purchase Plan on September 30, 2025 and March 31, 2026, respectively."}],"balance_after":102735,"source":{"system":"sec-edgar","filing":"0001193125-26-144080","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526144080/ownership.xml","form_type":"4"}},{"id":814628,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53619,"kind":"person","name":"Cavanagh Bethany J","position":1,"cik":"0002033155","reported_name":"Cavanagh Bethany J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance and Treasurer"}}],"security":"Common Stock","published_at":"2026-04-06T21:39:47.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":3242,"price":24.58,"value":79688.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. 2019 Equity Incentive Plan on each of March 31, 2022, March 31, 2023, March 31, 2024 and March 31, 2025. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 9, 2024."}],"balance_after":51171,"source":{"system":"sec-edgar","filing":"0001193125-26-144068","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2033155/000119312526144068/ownership.xml","form_type":"4"}},{"id":814478,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-04-06T21:39:44.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":5956,"price":24.58,"value":146398.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. 2019 Equity Incentive Plan on each of March 31, 2022, March 31, 2023, March 31, 2024 and March 31, 2025. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2023."}],"balance_after":109711,"source":{"system":"sec-edgar","filing":"0001193125-26-144067","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526144067/ownership.xml","form_type":"4"}},{"id":814477,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":36344,"kind":"person","name":"Ciaramella Giuseppe","position":1,"cik":"0001786322","reported_name":"Ciaramella Giuseppe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2026-04-06T21:34:38.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":11810,"price":24.58,"value":290289.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. 2019 Equity Incentive Plan on each of March 31, 2022, March 31, 2023, March 31, 2024 and March 31, 2025. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023."}],"balance_after":218406,"source":{"system":"sec-edgar","filing":"0001193125-26-144054","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526144054/ownership.xml","form_type":"4"}},{"id":819694,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-04-02T21:27:06.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSUs vest in four substantially equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with BEAM through each vesting date."}],"balance_after":115667,"source":{"system":"sec-edgar","filing":"0001193125-26-140586","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526140586/ownership.xml","form_type":"4"}},{"id":820313,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53619,"kind":"person","name":"Cavanagh Bethany J","position":1,"cik":"0002033155","reported_name":"Cavanagh Bethany J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance and Treasurer"}}],"security":"Common Stock","published_at":"2026-04-02T21:22:20.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSUs vest in four substantially equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with BEAM through each vesting date."}],"balance_after":54813,"source":{"system":"sec-edgar","filing":"0001193125-26-140553","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2033155/000119312526140553/ownership.xml","form_type":"4"}},{"id":819692,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":28026,"kind":"person","name":"Simon Amy","position":1,"cik":"0001963879","reported_name":"Simon Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-02T21:16:47.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":31750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSUs vest in four substantially equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with BEAM through each vesting date."}],"balance_after":109114,"source":{"system":"sec-edgar","filing":"0001193125-26-140515","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526140515/ownership.xml","form_type":"4"}},{"id":819693,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-02T21:16:13.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":31750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSUs vest in four substantially equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with BEAM through each vesting date."}],"balance_after":105456,"source":{"system":"sec-edgar","filing":"0001193125-26-140513","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526140513/ownership.xml","form_type":"4"}},{"id":819685,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":36344,"kind":"person","name":"Ciaramella Giuseppe","position":1,"cik":"0001786322","reported_name":"Ciaramella Giuseppe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2026-04-02T21:15:54.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSUs vest in four substantially equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with BEAM through each vesting date."}],"balance_after":230216,"source":{"system":"sec-edgar","filing":"0001193125-26-140508","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526140508/ownership.xml","form_type":"4"}},{"id":822924,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-01T22:32:14.000Z","date":"2026-03-31","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On May 8, 2018, the Reporting Person was granted an option to purchase shares of common stock, which vested as to 99,396 shares upon the achievement of a certain development milestone related to base editing applications. On April 3, 2024, the board of directors of BEAM determined that this performance condition was achieved, resulting in the vesting of 99,336 shares."}],"balance_after":18672,"derivative":{"exercise_price":0.67,"expiration_date":"2028-05-08","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001193125-26-138348","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526138348/ownership.xml","form_type":"4"}},{"id":822923,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-01T22:32:14.000Z","date":"2026-03-30","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On May 8, 2018, the Reporting Person was granted an option to purchase shares of common stock, which vested as to 99,396 shares upon the achievement of a certain development milestone related to base editing applications. On April 3, 2024, the board of directors of BEAM determined that this performance condition was achieved, resulting in the vesting of 99,336 shares."}],"balance_after":43672,"derivative":{"exercise_price":0.67,"expiration_date":"2028-05-08","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001193125-26-138348","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526138348/ownership.xml","form_type":"4"}},{"id":822922,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-04-01T22:32:14.000Z","date":"2026-03-31","kind":"grant","planned":true,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person under the BEAM 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSUs vest in four substantially equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with BEAM through each vesting date."}],"balance_after":1076667,"source":{"system":"sec-edgar","filing":"0001193125-26-138348","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526138348/ownership.xml","form_type":"4"}},{"id":822921,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-04-01T22:32:14.000Z","date":"2026-03-31","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":22.7634,"value":569085.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $22.34 to $23.21, inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":986667,"source":{"system":"sec-edgar","filing":"0001193125-26-138348","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526138348/ownership.xml","form_type":"4"}},{"id":822920,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-04-01T22:32:14.000Z","date":"2026-03-31","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":0.67,"value":16750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025."}],"balance_after":1011667,"source":{"system":"sec-edgar","filing":"0001193125-26-138348","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526138348/ownership.xml","form_type":"4"}},{"id":822919,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-04-01T22:32:14.000Z","date":"2026-03-30","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":22.3692,"value":559230.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $22.03 to $22.70, inclusive. The Reporting Person undertakes to provide to Beam Therapeutics Inc. (\"BEAM\"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":986667,"source":{"system":"sec-edgar","filing":"0001193125-26-138348","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526138348/ownership.xml","form_type":"4"}},{"id":822918,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-04-01T22:32:14.000Z","date":"2026-03-30","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":0.67,"value":16750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025."}],"balance_after":1011667,"source":{"system":"sec-edgar","filing":"0001193125-26-138348","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526138348/ownership.xml","form_type":"4"}},{"id":879750,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":36344,"kind":"person","name":"Ciaramella Giuseppe","position":1,"cik":"0001786322","reported_name":"Ciaramella Giuseppe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-26T21:05:04.000Z","date":"2026-02-24","kind":"exercise","planned":true,"acquired":false,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests as to 25% on the first anniversary of the of the vesting commencement date, February 5, 2020, and at a rate of 2.78% each month thereafter until the option is fully vested."}],"balance_after":397313,"derivative":{"exercise_price":17,"expiration_date":"2030-02-05","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001193125-26-076544","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526076544/ownership.xml","form_type":"4"}},{"id":879749,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":36344,"kind":"person","name":"Ciaramella Giuseppe","position":1,"cik":"0001786322","reported_name":"Ciaramella Giuseppe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2026-02-26T21:05:04.000Z","date":"2026-02-24","kind":"sale","planned":true,"acquired":false,"shares":35000,"price":32.0012,"value":1120042.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of Common Stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $32.00 to $32.04, inclusive. The Reporting Person undertakes to provide to Beam Therapeutics Inc. (\"BEAM\"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":190216,"source":{"system":"sec-edgar","filing":"0001193125-26-076544","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526076544/ownership.xml","form_type":"4"}},{"id":879748,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":36344,"kind":"person","name":"Ciaramella Giuseppe","position":1,"cik":"0001786322","reported_name":"Ciaramella Giuseppe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2026-02-26T21:05:04.000Z","date":"2026-02-24","kind":"exercise","planned":true,"acquired":true,"shares":35000,"price":17,"value":595000.0,"ownership":{"direct":true},"balance_after":225216,"source":{"system":"sec-edgar","filing":"0001193125-26-076544","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526076544/ownership.xml","form_type":"4"}},{"id":925550,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53619,"kind":"person","name":"Cavanagh Bethany J","position":1,"cik":"0002033155","reported_name":"Cavanagh Bethany J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance and Treasurer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-02T21:05:17.000Z","date":"2026-01-31","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests in equal monthly installments each month following the date of grant for the subsequent 48 months, subject to the Reporting Person's continued service with Beam Therapeutics Inc. through each vesting date."}],"balance_after":40000,"derivative":{"exercise_price":27.62,"expiration_date":"2036-01-31","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001193125-26-033605","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2033155/000119312526033605/ownership.xml","form_type":"4"}},{"id":925242,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":36344,"kind":"person","name":"Ciaramella Giuseppe","position":1,"cik":"0001786322","reported_name":"Ciaramella Giuseppe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-02T21:05:16.000Z","date":"2026-01-31","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests in equal monthly installments each month following the date of grant for the subsequent 48 months, subject to the Reporting Person's continued service with BEAM through each vesting date."}],"balance_after":80000,"derivative":{"exercise_price":27.62,"expiration_date":"2036-01-31","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001193125-26-033606","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526033606/ownership.xml","form_type":"4"}},{"id":925241,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-02T21:05:13.000Z","date":"2026-01-31","kind":"grant","planned":false,"acquired":true,"shares":63500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests in equal monthly installments each month following the date of grant for the subsequent 48 months, subject to the Reporting Person's continued service with Beam Therapeutics Inc. through each vesting date."}],"balance_after":63500,"derivative":{"exercise_price":27.62,"expiration_date":"2036-01-31","underlying":"Common Stock","underlying_shares":63500},"source":{"system":"sec-edgar","filing":"0001193125-26-033603","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526033603/ownership.xml","form_type":"4"}},{"id":925229,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-02T21:05:09.000Z","date":"2026-01-31","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests in equal monthly installments each month following the date of grant for the subsequent 48 months, subject to the Reporting Person's continued service with Beam Therapeutics Inc. through each vesting date."}],"balance_after":40000,"derivative":{"exercise_price":27.62,"expiration_date":"2036-01-31","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001193125-26-033601","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526033601/ownership.xml","form_type":"4"}},{"id":925240,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-02T21:05:08.000Z","date":"2026-01-31","kind":"grant","planned":true,"acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This stock option vests in equal monthly installments each month following the date of grant for the subsequent 48 months, subject to the Reporting Person's continued service with BEAM through each vesting date."}],"balance_after":180000,"derivative":{"exercise_price":27.62,"expiration_date":"2036-01-31","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001193125-26-033600","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526033600/ownership.xml","form_type":"4"}},{"id":925239,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-02T21:05:08.000Z","date":"2026-01-30","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On May 8, 2018, the Reporting Person was granted an option to purchase shares of common stock, which vested as to 99,396 shares upon the achievement of a certain development milestone related to base editing applications. On April 3, 2024, the board of directors of BEAM determined that this performance condition was achieved, resulting in the vesting of 99,336 shares."}],"balance_after":68672,"derivative":{"exercise_price":0.67,"expiration_date":"2028-05-08","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001193125-26-033600","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526033600/ownership.xml","form_type":"4"}},{"id":925238,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-02T21:05:08.000Z","date":"2026-01-29","kind":"exercise","planned":true,"acquired":false,"shares":5664,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On May 8, 2018, the Reporting Person was granted an option to purchase shares of common stock, which vested as to 99,396 shares upon the achievement of a certain development milestone related to base editing applications. On April 3, 2024, the board of directors of BEAM determined that this performance condition was achieved, resulting in the vesting of 99,336 shares."}],"balance_after":93672,"derivative":{"exercise_price":0.67,"expiration_date":"2028-05-08","underlying":"Common Stock","underlying_shares":5664},"source":{"system":"sec-edgar","filing":"0001193125-26-033600","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526033600/ownership.xml","form_type":"4"}},{"id":925237,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-02T21:05:08.000Z","date":"2026-01-29","kind":"exercise","planned":true,"acquired":false,"shares":19336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On May 8, 2018, the Reporting Person was granted an option to purchase shares of common stock, which vested as to 99,396 shares upon the achievement of a closing hurdle following BEAM's initial public offering (which closing price hurdle was achieved) (the \"Price Condition\"). The portion of the award subject to the Price Condition vested in three equal installments on December 21, 2021, June 30, 2022, and December 31, 2022."}],"balance_after":0,"derivative":{"exercise_price":0.67,"expiration_date":"2028-05-08","underlying":"Common Stock","underlying_shares":19336},"source":{"system":"sec-edgar","filing":"0001193125-26-033600","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526033600/ownership.xml","form_type":"4"}},{"id":925236,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-02-02T21:05:08.000Z","date":"2026-01-30","kind":"sale","planned":true,"acquired":false,"shares":2906,"price":29,"value":84274.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025."}],"balance_after":986667,"source":{"system":"sec-edgar","filing":"0001193125-26-033600","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526033600/ownership.xml","form_type":"4"}},{"id":925235,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-02-02T21:05:08.000Z","date":"2026-01-30","kind":"sale","planned":true,"acquired":false,"shares":22094,"price":28.2734,"value":624672.4996,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $27.87 to $28.82 inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":989573,"source":{"system":"sec-edgar","filing":"0001193125-26-033600","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526033600/ownership.xml","form_type":"4"}},{"id":925234,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-02-02T21:05:08.000Z","date":"2026-01-30","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":0.67,"value":16750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025."}],"balance_after":1011667,"source":{"system":"sec-edgar","filing":"0001193125-26-033600","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526033600/ownership.xml","form_type":"4"}},{"id":925233,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-02-02T21:05:08.000Z","date":"2026-01-29","kind":"sale","planned":true,"acquired":false,"shares":8667,"price":29.7428,"value":257780.8476,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $29.66 to $29.92 inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":986667,"source":{"system":"sec-edgar","filing":"0001193125-26-033600","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526033600/ownership.xml","form_type":"4"}},{"id":925232,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-02-02T21:05:08.000Z","date":"2026-01-29","kind":"sale","planned":true,"acquired":false,"shares":16333,"price":29.1925,"value":476801.1025,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $28.65 to $29.64 inclusive. The Reporting Person undertakes to provide to Beam Therapeutics Inc. (\"BEAM\"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":995334,"source":{"system":"sec-edgar","filing":"0001193125-26-033600","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526033600/ownership.xml","form_type":"4"}},{"id":925231,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-02-02T21:05:08.000Z","date":"2026-01-29","kind":"exercise","planned":true,"acquired":true,"shares":5664,"price":0.67,"value":3794.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025."}],"balance_after":1011667,"source":{"system":"sec-edgar","filing":"0001193125-26-033600","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526033600/ownership.xml","form_type":"4"}},{"id":925230,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-02-02T21:05:08.000Z","date":"2026-01-29","kind":"exercise","planned":true,"acquired":true,"shares":19336,"price":0.67,"value":12955.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025."}],"balance_after":1006003,"source":{"system":"sec-edgar","filing":"0001193125-26-033600","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526033600/ownership.xml","form_type":"4"}},{"id":925224,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":28026,"kind":"person","name":"Simon Amy","position":1,"cik":"0001963879","reported_name":"Simon Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-02T21:05:05.000Z","date":"2026-01-31","kind":"grant","planned":false,"acquired":true,"shares":88500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests in equal monthly installments each month following the date of grant for the subsequent 48 months, subject to the Reporting Person's continued service with Beam Therapeutics Inc. through each vesting date."}],"balance_after":88500,"derivative":{"exercise_price":27.62,"expiration_date":"2036-01-31","underlying":"Common Stock","underlying_shares":88500},"source":{"system":"sec-edgar","filing":"0001193125-26-033598","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526033598/ownership.xml","form_type":"4"}},{"id":931289,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53619,"kind":"person","name":"Cavanagh Bethany J","position":1,"cik":"0002033155","reported_name":"Cavanagh Bethany J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance and Treasurer"}}],"security":"Common Stock","published_at":"2026-01-26T21:05:05.000Z","date":"2026-01-22","kind":"sale","planned":true,"acquired":false,"shares":6198,"price":35.0005,"value":216933.099,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of Common Stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $35.00 to $35.015, inclusive. The Reporting Person undertakes to provide to Beam Therapeutics Inc. (\"BEAM\"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":34813,"source":{"system":"sec-edgar","filing":"0001193125-26-022563","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2033155/000119312526022563/ownership.xml","form_type":"4"}},{"id":931195,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-01-26T21:05:02.000Z","date":"2026-01-22","kind":"sale","planned":true,"acquired":false,"shares":1371,"price":34,"value":46614.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 16, 2025."}],"balance_after":95667,"source":{"system":"sec-edgar","filing":"0001193125-26-022557","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526022557/ownership.xml","form_type":"4"}},{"id":934433,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53619,"kind":"person","name":"Cavanagh Bethany J","position":1,"cik":"0002033155","reported_name":"Cavanagh Bethany J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance and Treasurer"}}],"security":"Common Stock","published_at":"2026-01-21T21:05:04.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":3034,"price":30.12,"value":91384.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of Common Stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025."}],"balance_after":41011,"source":{"system":"sec-edgar","filing":"0001193125-26-017942","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2033155/000119312526017942/ownership.xml","form_type":"4"}},{"id":935428,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-01-20T21:05:03.000Z","date":"2026-01-15","kind":"sale","planned":true,"acquired":false,"shares":559,"price":35.3988,"value":19787.9292,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 16, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $35.38 to $35.485, inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":97038,"source":{"system":"sec-edgar","filing":"0001193125-26-016552","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526016552/ownership.xml","form_type":"4"}},{"id":935427,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-01-20T21:05:03.000Z","date":"2026-01-15","kind":"sale","planned":true,"acquired":false,"shares":15959,"price":34.7182,"value":554067.7538,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 16, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $34.355 to $35.34, inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":97597,"source":{"system":"sec-edgar","filing":"0001193125-26-016552","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526016552/ownership.xml","form_type":"4"}},{"id":935426,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-01-20T21:05:03.000Z","date":"2026-01-15","kind":"sale","planned":true,"acquired":false,"shares":2111,"price":33.6219,"value":70975.8309,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 16, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $33.17 to $34.15, inclusive. The Reporting Person undertakes to provide to Beam Therapeutics Inc. (\"BEAM\"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":113556,"source":{"system":"sec-edgar","filing":"0001193125-26-016552","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526016552/ownership.xml","form_type":"4"}},{"id":951670,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-05T21:16:08.000Z","date":"2025-12-31","kind":"sale","planned":true,"acquired":false,"shares":6294,"price":27.1,"value":170567.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") 2019 Equity Incentive Plan on December 30, 2022. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2025."}],"balance_after":73706,"source":{"system":"sec-edgar","filing":"0001193125-26-002448","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526002448/ownership.xml","form_type":"4"}},{"id":951669,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-01-05T21:12:50.000Z","date":"2025-12-31","kind":"sale","planned":true,"acquired":false,"shares":1254,"price":27.1,"value":33983.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") 2019 Equity Incentive Plan on December 30, 2022. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2023."}],"balance_after":115667,"source":{"system":"sec-edgar","filing":"0001193125-26-002427","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526002427/ownership.xml","form_type":"4"}},{"id":951668,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":28026,"kind":"person","name":"Simon Amy","position":1,"cik":"0001963879","reported_name":"Simon Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-05T21:11:15.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSUs vest in four substantially equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with BEAM through each vesting date."}],"balance_after":77364,"source":{"system":"sec-edgar","filing":"0001193125-26-002422","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526002422/ownership.xml","form_type":"4"}},{"id":1012306,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":28868,"kind":"organization","name":"FMR LLC","position":1,"cik":"0000315066","reported_name":"FMR LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remark 1"}}],"security":"Common Stock","published_at":"2025-10-29T17:13:52.000Z","date":"2025-10-27","kind":"sale","planned":false,"acquired":false,"shares":459,"price":26.68,"value":12246.12,"ownership":{"direct":false,"nature":"FMR Capital, Inc."},"balance_after":14,"source":{"system":"sec-edgar","filing":"0001193125-25-255853","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/315066/000119312525255853/ownership.xml","form_type":"4"}},{"id":1021879,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":28868,"kind":"organization","name":"FMR LLC","position":1,"cik":"0000315066","reported_name":"FMR LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remark 1"}}],"security":"Common Stock","published_at":"2025-10-08T19:37:41.000Z","date":"2025-10-06","kind":"gift","planned":false,"acquired":false,"shares":1232434,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Shares held by persons and entities whose shares are subject to reporting by the undersigned."},"balance_after":841231,"source":{"system":"sec-edgar","filing":"0001193125-25-234461","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/315066/000119312525234461/ownership.xml","form_type":"4"}},{"id":1024963,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53619,"kind":"person","name":"Cavanagh Bethany J","position":1,"cik":"0002033155","reported_name":"Cavanagh Bethany J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance and Treasurer"}}],"security":"Common Stock","published_at":"2025-10-03T20:15:03.000Z","date":"2025-10-01","kind":"sale","planned":true,"acquired":false,"shares":467,"price":24.53,"value":11455.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. 2019 Equity Incentive Plan on September 30, 2021 and September 30, 2024. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 9, 2024."}],"balance_after":44045,"source":{"system":"sec-edgar","filing":"0001193125-25-230195","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2033155/000119312525230195/ownership.xml","form_type":"4"}},{"id":1024649,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-10-03T20:10:15.000Z","date":"2025-10-01","kind":"sale","planned":true,"acquired":false,"shares":373,"price":24.53,"value":9149.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. 2019 Equity Incentive Plan on September 30, 2021. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2023."}],"balance_after":116921,"source":{"system":"sec-edgar","filing":"0001193125-25-230148","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312525230148/ownership.xml","form_type":"4"}},{"id":1024648,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-03T20:05:03.000Z","date":"2025-10-02","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On May 8, 2018, the Reporting Person was granted an option to purchase shares of common stock, which vested as to 99,396 shares upon the achievement of a closing hurdle following BEAM's initial public offering (which closing price hurdle was achieved) (the \"Price Condition\"). The portion of the award subject to the Price Condition vested in three equal installments on December 21, June 30, 2022, and December 31, 2022."}],"balance_after":19336,"derivative":{"exercise_price":0.67,"expiration_date":"2028-05-08","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001193125-25-230084","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312525230084/ownership.xml","form_type":"4"}},{"id":1024647,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-03T20:05:03.000Z","date":"2025-10-01","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On May 8, 2018, the Reporting Person was granted an option to purchase shares of common stock, which vested as to 99,396 shares upon the achievement of a closing hurdle following BEAM's initial public offering (which closing price hurdle was achieved) (the \"Price Condition\"). The portion of the award subject to the Price Condition vested in three equal installments on December 21, June 30, 2022, and December 31, 2022."}],"balance_after":44336,"derivative":{"exercise_price":0.67,"expiration_date":"2028-05-08","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001193125-25-230084","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312525230084/ownership.xml","form_type":"4"}},{"id":1024646,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-10-03T20:05:03.000Z","date":"2025-10-02","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":24.6267,"value":615667.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $24.22 to $25.05, inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":986667,"source":{"system":"sec-edgar","filing":"0001193125-25-230084","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312525230084/ownership.xml","form_type":"4"}},{"id":1024645,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-10-03T20:05:03.000Z","date":"2025-10-02","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":0.67,"value":16750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025."}],"balance_after":1011667,"source":{"system":"sec-edgar","filing":"0001193125-25-230084","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312525230084/ownership.xml","form_type":"4"}},{"id":1024644,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-10-03T20:05:03.000Z","date":"2025-10-01","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":24.5062,"value":612655.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $24.14 to $24.92, inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":986667,"source":{"system":"sec-edgar","filing":"0001193125-25-230084","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312525230084/ownership.xml","form_type":"4"}},{"id":1024643,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-10-03T20:05:03.000Z","date":"2025-10-01","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":0.67,"value":16750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 418 shares acquired by the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") Amended and Restated 2019 Employee Stock Purchase Plan on September 30, 2025."}],"balance_after":1011667,"source":{"system":"sec-edgar","filing":"0001193125-25-230084","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312525230084/ownership.xml","form_type":"4"}},{"id":1077966,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":28868,"kind":"organization","name":"FMR LLC","position":1,"cik":"0000315066","reported_name":"FMR LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remark 1"}}],"security":"Common Stock","published_at":"2025-08-01T13:36:26.000Z","date":"2025-07-30","kind":"sale","planned":false,"acquired":false,"shares":48374,"price":20.5,"value":991667.0,"ownership":{"direct":false,"nature":"Shares held by persons and entities whose shares are subject to reporting by the undersigned."},"balance_after":2073665,"source":{"system":"sec-edgar","filing":"0000950170-25-101143","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/315066/000095017025101143/ownership.xml","form_type":"4"}},{"id":1092541,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":28026,"kind":"person","name":"Simon Amy","position":1,"cik":"0001963879","reported_name":"Simon Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-07-03T21:30:05.000Z","date":"2025-07-03","kind":"sale","planned":true,"acquired":false,"shares":876,"price":20.12,"value":17625.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These shares of common stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2024."}],"balance_after":64864,"source":{"system":"sec-edgar","filing":"0000950170-25-094002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025094002/ownership.xml","form_type":"4"}},{"id":1092540,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":28026,"kind":"person","name":"Simon Amy","position":1,"cik":"0001963879","reported_name":"Simon Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-07-03T21:30:05.000Z","date":"2025-07-01","kind":"sale","planned":true,"acquired":false,"shares":374,"price":16.9423,"value":6336.4202,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") 2019 Equity Incentive Plan on June 30, 2022. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 372 shares acquired by the Reporting Person under the BEAM Amended and Restated 2019 Employee Stock Purchase Plan on September 30, 2024."}],"balance_after":65740,"source":{"system":"sec-edgar","filing":"0000950170-25-094002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025094002/ownership.xml","form_type":"4"}},{"id":1119722,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40950,"kind":"person","name":"Walsh Kathleen E","position":1,"cik":"0001667866","reported_name":"Walsh Kathleen E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T20:05:30.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":33662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the first anniversary of the date of grant and immediately prior to the date of the next year's annual meeting of stockholders, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date."}],"balance_after":33662,"derivative":{"exercise_price":17.15,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":33662},"source":{"system":"sec-edgar","filing":"0000950170-25-083056","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025083056/ownership.xml","form_type":"4"}},{"id":1119720,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40949,"kind":"person","name":"Fishman Mark","position":1,"cik":"0001786003","reported_name":"Fishman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T20:05:28.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":33662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the first anniversary of the date of grant and immediately prior to the date of the next year's annual meeting of stockholders, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date."}],"balance_after":33662,"derivative":{"exercise_price":17.15,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":33662},"source":{"system":"sec-edgar","filing":"0000950170-25-083055","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025083055/ownership.xml","form_type":"4"}},{"id":1119721,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":11980,"kind":"person","name":"Shaw Christi","position":1,"cik":"0001702473","reported_name":"Shaw Christi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T20:05:26.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":33662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the first anniversary of the date of grant and immediately prior to the date of the next year's annual meeting of stockholders, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date."}],"balance_after":33662,"derivative":{"exercise_price":17.15,"expiration_date":"2025-06-04","underlying":"Common Stock","underlying_shares":33662},"source":{"system":"sec-edgar","filing":"0000950170-25-083054","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025083054/ownership.xml","form_type":"4"}},{"id":1119719,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":11152,"kind":"person","name":"Ho Carole","position":1,"cik":"0001724605","reported_name":"Ho Carole","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T20:05:23.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":33662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the first anniversary of the date of grant and immediately prior to the date of the next year's annual meeting of stockholders, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date."}],"balance_after":33662,"derivative":{"exercise_price":17.15,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":33662},"source":{"system":"sec-edgar","filing":"0000950170-25-083051","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025083051/ownership.xml","form_type":"4"}},{"id":1119996,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":32216,"kind":"person","name":"MARAGANORE JOHN","position":1,"cik":"0001180432","reported_name":"MARAGANORE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T20:05:21.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":33662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the first anniversary of the date of grant and immediately prior to the date of the next year's annual meeting of stockholders, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date."}],"balance_after":33662,"derivative":{"exercise_price":17.15,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":33662},"source":{"system":"sec-edgar","filing":"0000950170-25-083053","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180432/000095017025083053/ownership.xml","form_type":"4"}},{"id":1119718,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T20:05:20.000Z","date":"2025-06-04","kind":"grant","planned":true,"acquired":true,"shares":33662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the first anniversary of the date of grant and immediately prior to the date of the next year's annual meeting of stockholders, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date."}],"balance_after":33662,"derivative":{"exercise_price":17.15,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":33662},"source":{"system":"sec-edgar","filing":"0000950170-25-083050","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025083050/ownership.xml","form_type":"4"}},{"id":1119717,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T20:05:19.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":33662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the first anniversary of the date of grant and immediately prior to the date of the next year's annual meeting of stockholders, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date."}],"balance_after":33662,"derivative":{"exercise_price":17.15,"expiration_date":"2025-06-04","underlying":"Common Stock","underlying_shares":33662},"source":{"system":"sec-edgar","filing":"0000950170-25-083052","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025083052/ownership.xml","form_type":"4"}},{"id":1179737,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-04-04T01:53:04.000Z","date":"2025-04-01","kind":"sale","planned":true,"acquired":false,"shares":5674,"price":18.3507,"value":104121.8718,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") 2019 Equity Incentive Plan on each of March 31, 2021, March 31, 2022, March 31, 2023 and March 31, 2024. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.76 to $18.38, inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":117294,"source":{"system":"sec-edgar","filing":"0000950170-25-050859","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025050859/ownership.xml","form_type":"4"}},{"id":1179738,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":34011,"kind":"person","name":"Evans John M.","position":1,"cik":"0001786304","reported_name":"Evans John M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-04-04T01:52:04.000Z","date":"2025-04-01","kind":"sale","planned":true,"acquired":false,"shares":30663,"price":18.3506,"value":562684.4478,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") 2019 Equity Incentive Plan on each of March 31, 2021, March 31, 2022, March 31, 2023 and March 31, 2024. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.76 to $18.38, inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 753 shares acquired by the Reporting Person under the BEAM Amended and Restated 2019 Employee Stock Purchase Plan on March 31, 2025."}],"balance_after":986249,"source":{"system":"sec-edgar","filing":"0000950170-25-050857","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025050857/ownership.xml","form_type":"4"}},{"id":1179736,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":36344,"kind":"person","name":"Ciaramella Giuseppe","position":1,"cik":"0001786322","reported_name":"Ciaramella Giuseppe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2025-04-04T01:51:57.000Z","date":"2025-04-01","kind":"sale","planned":true,"acquired":false,"shares":7434,"price":18.3506,"value":136418.3604,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") 2019 Equity Incentive Plan on each of March 31, 2021, March 31, 2022, March 31, 2023 and March 31, 2024. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.76 to $18.38, inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":190216,"source":{"system":"sec-edgar","filing":"0000950170-25-050856","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025050856/ownership.xml","form_type":"4"}},{"id":1180317,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53619,"kind":"person","name":"Cavanagh Bethany J","position":1,"cik":"0002033155","reported_name":"Cavanagh Bethany J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance and Treasurer"}}],"security":"Common Stock","published_at":"2025-04-04T01:50:50.000Z","date":"2025-04-01","kind":"sale","planned":true,"acquired":false,"shares":3015,"price":18.3516,"value":55330.074,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") 2019 Equity Incentive Plan on each of March 31, 2021, March 31, 2022, March 31, 2023 and March 31, 2024. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 9, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.76 to $18.38, inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":44512,"source":{"system":"sec-edgar","filing":"0000950170-25-050855","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2033155/000095017025050855/ownership.xml","form_type":"4"}},{"id":1179734,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":28026,"kind":"person","name":"Simon Amy","position":1,"cik":"0001963879","reported_name":"Simon Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-04-04T01:50:11.000Z","date":"2025-04-02","kind":"sale","planned":true,"acquired":false,"shares":20997,"price":17.7308,"value":372293.6076,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The shares of common stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.20 to $18.12, inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission , upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":65742,"source":{"system":"sec-edgar","filing":"0000950170-25-050852","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025050852/ownership.xml","form_type":"4"}},{"id":1179733,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":28026,"kind":"person","name":"Simon Amy","position":1,"cik":"0001963879","reported_name":"Simon Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-04-04T01:50:11.000Z","date":"2025-04-01","kind":"sale","planned":true,"acquired":false,"shares":9566,"price":18.3506,"value":175541.8396,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") 2019 Equity Incentive Plan on each of March 31, 2021, March 31, 2022, March 31, 2023 and March 31, 2024. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.76 to $18.38, inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":86739,"source":{"system":"sec-edgar","filing":"0000950170-25-050852","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025050852/ownership.xml","form_type":"4"}},{"id":1183622,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":53594,"kind":"person","name":"Bellon Christine","position":1,"cik":"0001963878","reported_name":"Bellon Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-04-02T23:21:37.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSUs vest in four substantially equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with BEAM through each vesting date."}],"balance_after":122968,"source":{"system":"sec-edgar","filing":"0000950170-25-049769","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025049769/ownership.xml","form_type":"4"}},{"id":1183621,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":28026,"kind":"person","name":"Simon Amy","position":1,"cik":"0001963879","reported_name":"Simon Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-04-02T23:18:23.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSUs vest in four substantially equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with BEAM through each vesting date."}],"balance_after":96305,"source":{"system":"sec-edgar","filing":"0000950170-25-049765","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025049765/ownership.xml","form_type":"4"}},{"id":1183616,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":36344,"kind":"person","name":"Ciaramella Giuseppe","position":1,"cik":"0001786322","reported_name":"Ciaramella Giuseppe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2025-04-02T23:13:53.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSUs vest in four substantially equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with BEAM through each vesting date."}],"balance_after":197650,"source":{"system":"sec-edgar","filing":"0000950170-25-049763","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025049763/ownership.xml","form_type":"4"}}],"next_cursor":"2025-04-02T23:13:53.000000Z,1183616"}